Related references
Note: Only part of the references are listed.miR-146a Polymorphism Influences Levels of miR-146a, IRAK-1, and TRAF-6 in Young Patients with Coronary Artery Disease
Prithiksha Ramkaran et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2014)
A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression
Xing-dong Xiong et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2014)
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
Cameron R. Stewart et al.
NATURE IMMUNOLOGY (2010)
Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer
Krystian Jazdzewski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Chlamydia pneumoniae-Induced Foam Cell Formation Requires MyD88-Dependent and -Independent Signaling and Is Reciprocally Modulated by Liver X Receptor Activation
Shuang Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
Serum C-reactive protein response to percutaneous coronary intervention in patients with unstable or stable angina pectoris is associated with the risk of clinical restenosis
Nawsad Saleh et al.
ATHEROSCLEROSIS (2007)
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
Luke A. J. O'Neill et al.
NATURE REVIEWS IMMUNOLOGY (2007)
NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses
Konstantin D. Taganov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Central role of endogenous Toll-like receptor-2 activation in regulating inflammation, reactive oxygen species production, and subsequent neointimal formation after vascular injury
T Shishido et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Toll-like receptor signaling and atherosclerosis
Kathrin S. Michelsen et al.
CURRENT OPINION IN HEMATOLOGY (2006)
A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis
L Hamann et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Stent implantation, but not pathogen burden, is associated with plasma C-reactive protein and interleukin-6 levels after percutaneous coronary intervention in patients with stable angina pectoris
N Saleh et al.
AMERICAN HEART JOURNAL (2005)
A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein
A Kovacs et al.
ATHEROSCLEROSIS (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Genetic predisposition of the interleukin-6 response to inflammation: Implications for a variety of major diseases?
M Bennermo et al.
CLINICAL CHEMISTRY (2004)
Immunosuppressive therapy for the prevention of restenosis after coronary artery stent implantation (IMPRESS study)
F Versaci et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)